FDA Inspection 1244787 — Altasciences CDMO Philadelphia, LLC
The FDA completed an inspection of Altasciences CDMO Philadelphia, LLC on July 26, 2024 in Harleysville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Harleysville, PA (United States)